Healthcare -
Biotechnology - NASDAQ - US
$ 38.51
-1.56 %
$ 2.3 B
Market Cap
14.05
P/E
PTGX - STOCK-BASED COMPENSATION
Stock-based Compensation PTGX - Protagonist Therapeutics, Inc.
29.3 M
LAST VALUE
33.67%
2 YEAR CAGR
33.46%
5 YEAR CAGR
0.00%
10 YEAR CAGR